Stryker Corp (SYK)
330.86
+1.58
(+0.48%)
USD |
NYSE |
May 09, 16:00
330.80
-0.06
(-0.02%)
Pre-Market: 20:00
Stryker Cash from Financing (TTM): -1.531B for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.531B |
| December 31, 2023 | -1.594B |
| September 30, 2023 | -1.754B |
| June 30, 2023 | -1.875B |
| March 31, 2023 | -2.223B |
| December 31, 2022 | -749.00M |
| September 30, 2022 | -591.00M |
| June 30, 2022 | -396.00M |
| March 31, 2022 | -319.00M |
| December 31, 2021 | -2.365B |
| September 30, 2021 | -3.134B |
| June 30, 2021 | -3.028B |
| March 31, 2021 | -296.00M |
| December 31, 2020 | -11.00M |
| September 30, 2020 | 3.409B |
| June 30, 2020 | 3.426B |
| March 31, 2020 | 1.182B |
| December 31, 2019 | 3.00M |
| September 30, 2019 | -80.00M |
| June 30, 2019 | -34.00M |
| March 31, 2019 | -763.00M |
| December 31, 2018 | 1.329B |
| September 30, 2018 | -1.223B |
| June 30, 2018 | -1.389B |
| March 31, 2018 | -512.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -794.00M |
| September 30, 2017 | -574.00M |
| June 30, 2017 | -1.177B |
| March 31, 2017 | -1.138B |
| December 31, 2016 | 2.258B |
| September 30, 2016 | 2.389B |
| June 30, 2016 | 3.086B |
| March 31, 2016 | 2.77B |
| December 31, 2015 | -1.223B |
| September 30, 2015 | -1.384B |
| June 30, 2015 | -1.189B |
| March 31, 2015 | -288.00M |
| December 31, 2014 | 629.00M |
| September 30, 2014 | 558.00M |
| June 30, 2014 | 509.00M |
| March 31, 2014 | -168.00M |
| December 31, 2013 | 300.00M |
| September 30, 2013 | 390.00M |
| June 30, 2013 | 385.00M |
| March 31, 2013 | 330.00M |
| December 31, 2012 | -449.00M |
| September 30, 2012 | -525.00M |
| June 30, 2012 | -27.00M |
| March 31, 2012 | 100.00M |
| December 31, 2011 | -161.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.134B
Minimum
Sep 2021
3.426B
Maximum
Jun 2020
-598.00M
Average
-493.50M
Median
Cash from Financing (TTM) Benchmarks
| Boston Scientific Corp | 1.643B |
| Haemonetics Corp | 100.06M |
| Abbott Laboratories | -6.857B |
| Zimmer Biomet Holdings Inc | -606.90M |
| ResMed Inc | -914.60M |